BVEGBangkok Vaccine Evaluation Group
References in periodicals archive ?
The announcement was made after VaxGen and BVEG reached their goal of enrolling 2,500 participants in the phase III clinical trial.
Kachit Choopanya, the trial's principal investigator and head of BVEG.
The trial is being conducted by BVEG, a collaboration of the Bangkok Metropolitan Administration, Mahidol University, the U.